![61IDwraZDrL._CLa|1516,1246|61YgalE5SgL.jpg,613jEy9fLKL.jpg|0,0,689,1246+827,0,689,1246+344,0,827,1246__AC_CR0,0,0,0_SY315_.jpg 61IDwraZDrL._CLa|1516,1246|61YgalE5SgL.jpg,613jEy9fLKL.jpg|0,0,689,1246+827,0,689,1246+344,0,827,1246__AC_CR0,0,0,0_SY315_.jpg](https://m.media-amazon.com/images/I/61IDwraZDrL._CLa%7C1516%2C1246%7C61YgalE5SgL.jpg%2C613jEy9fLKL.jpg%7C0%2C0%2C689%2C1246%2B827%2C0%2C689%2C1246%2B344%2C0%2C827%2C1246__AC_CR0%2C0%2C0%2C0_SY315_.jpg)
61IDwraZDrL._CLa|1516,1246|61YgalE5SgL.jpg,613jEy9fLKL.jpg|0,0,689,1246+827,0,689,1246+344,0,827,1246__AC_CR0,0,0,0_SY315_.jpg
![Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.1c05099/asset/images/large/nn1c05099_0006.jpeg)
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano
![Quantitative Proteome Profiling of Normal Human Circulating Microparticles | Journal of Proteome Research Quantitative Proteome Profiling of Normal Human Circulating Microparticles | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/pr200901p/asset/images/medium/pr-2011-00901p_0007.gif)